The German government has released information regarding the 20% discounts to combination products e...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreHope that new action plan and collaboration with the rare diseases community will progress positive ...
Read moreWe've prepared an analysis of the top 10 most expensive drugs in the US compared with Germany, in th...
Read moreAmong the most expensive therapies are gene therapies that show promise to transform inherited disor...
Read moreIn a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys...
Read moreJapan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy...
Read moreThe company found themselves facing competitive tenders for the first time in this disease space - t...
Read moreWe summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read more